Back to Agenda
Session 8: Senior Leaders Town Hall: Bridging Statistical Science with Data Science in Drug Development
Session Chair(s)
Jingyu (Julia) Luan, PhD
Executive Regulatory Science Director , AstraZeneca, United States
Cristiana Mayer, DRSc, PhD
Head of Biostatistics, Johnson & Johnson Vision, United States
Learning Objective : At the conclusion of this session, participants should be able to:- Understand the collaboration of statistical science with data science in drug development
- Understand what has changed in the role of the statistician
- Describe opportunities for drug development based on advancements in new technologies and data analytics
Speaker(s)
Speaker
Aloka Chakravarty, PhD
Director, Data Analytics, Office of Data, Analytics, & Research, Office of the Commissioner, FDA, United States
Speaker
Eric Gibson, PhD
VP, Global Head Biostatistical Sciences and Pharmacometrics, Novartis Pharmaceuticals Corporation, United States
Speaker
Cyrus Hoseyni, PhD
VP & Global Head of Statistics and Decision Sciences, Janssen R&D, United States
Speaker
Lisa Lupinacci, PhD, MS
Senior Vice President, Biostatistics and Research Decision Sciences, Merck and Co., Inc., United States
Speaker
John Scott, PhD, MA
Division Director, Office of Biostatistics, CBER, FDA, United States
Speaker
Ram Tiwari, PhD, MS
Head of Statistical Methodology, Bristol Myres Squibb , United States
Have an account?